Mskcc Renal Cell Carcinoma Risk Stratification

Motzer s research focuses on renal cell carcinoma germ cell tumors and bone marrow and blood cell.
Mskcc renal cell carcinoma risk stratification. Our kidney cancer nomogram is a prediction tool designed to help patients and their physicians calculate the likely outcome of their surgical treatment for newly diagnosed renal cell carcinoma a type of kidney cancer. Who can use this tool. It is based on the 670 patient original 1999 study by robert j motzer md at the memorial sloan kettering cancer center mskcc and is the most widely recognized prognostic algorithm for rcc. He received the career development award from the national institutes of health and the schonfeld award from the kidney cancer association.
The renal cell carcinoma tool consists of the motzer score resulted from the memorial sloan kettering cancer center mskcc study and the extended version created by mekhail. Motzer md is a medical oncologist at memorial sloan kettering cancer center. This nomogram was designed to be used by physicians and people with renal cell carcinoma. If you are a patient we recommend that you use this tool in consultation with your.
Our renal cell carcinoma nomogram is an online tool that can be used to predict the likelihood that a patient s kidney cancer will not recur at five years after surgery following a new diagnosis.